Coronavirus (COVID-19) Update: FDA Limits Use of Certain Monoclonal Antibodies to Treat COVID-19 Due to the Omicron Variant
FDA Statement The following is attributed to Patrizia Cavazzoni, M.D., director of the FDA’s Center for Drug Evaluation and Research For Immediate Release: January 24, 2022 Statement From: Patrizia Cavazzoni, M.D. Director - Center for Drug Evaluation and …